Malignant teratoma of ovary
ORPHA:398987DiseaseUnknownAdolescent, Adult, Childhood, Infancy
Ассоциированные гены1
Эпидемиология24
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only |
| Annual incidence | <1 / 1 000 000 | 0.07 | Europe | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.051 | Austria | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.052 | Belgium | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.043 | Bulgaria | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.056 | Croatia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.034 | Czech Republic | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.074 | Estonia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.053 | Finland | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.042 | Germany | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.052 | Ireland | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.039 | Italy | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.027 | Latvia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.017 | Lithuania | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.031 | Malta | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.084 | Norway | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.048 | Poland | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.045 | Portugal | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.045 | Slovakia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.075 | Slovenia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.063 | Spain | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.084 | Switzerland | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.082 | Netherlands | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.056 | United Kingdom | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)